AI assistant
DEXCOM INC — Director's Dealing 2015
Dec 17, 2015
30198_dirs_2015-12-17_7b72bd26-c0cf-4012-873e-ae0f7920dd32.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-12-15
Reporting Person: SAYER KEVIN R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-15 | Common Stock | G | 2500.0 | $0.0 | Disposed | 343402 | Direct |
Footnotes
F1: This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Mr. Sayer is a member of the board of directors of the DexCom One Step Ahead Foundation (DOSAF). If in his capacity as a director of DOSAF, Mr. Sayer is deemed to have a beneficial ownership interest in the shares of stock he is donating to DOSAF, Mr. Sayer disclaims such beneficial ownership interest.
F2: Included in this number are 190,000 unvested restricted stock units, 90,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 75,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 25,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.